Tweet
Translation Google
Haut-Mbomou: Launch of preventive vaccination against Ebola in Obo
March 19, 2026
(audio)
Following Bangui and several provinces, the city of Obo officially launched its preventive vaccination campaign against the Ebola virus on Tuesday, March 17. This operation primarily targets healthcare workers and members of the defense and security forces, considered the most exposed groups. By Aymard Gilles Quentin Mocki. We listen to him in remarks collected by Aymard Gilles Quentin Mocki.
The launch ceremony took place at the Obo District Hospital in the presence of local and health authorities. This initiative is part of a national strategy aimed at anticipating any epidemic risk by strengthening the immunity of frontline workers. The chief medical officer of the Haut-Mbomou health district, Dr. Armand Guezza, explained that the selection of beneficiaries reflects a need for strategic management of medical resources. Lacking sufficient stocks to cover the entire population, the government opted for targeted protection of professional categories considered at risk.
A strategic targeting of frontline actors
The program gives absolute priority to doctors, nurses, midwives, nursing assistants, community health workers, and laboratory personnel. Defense and security forces are also included as a secondary component. This rigorous selection process ensures the safety of those in direct contact with potential suspected cases, thus guaranteeing the continuity of health and security services in the event of an alert.
Four days of health mobilization
The campaign, scheduled to last four days, has already generated considerable enthusiasm, with many volunteers turning up as soon as it opened. To ensure the smooth running of the operation, two vaccination sites have been set up in the city: the Obo District Hospital and the AIM Medical Center. The strong involvement of administrative authorities and community health workers demonstrates the local commitment to strengthening health resilience in the face of cross-border infectious disease threats.
Haut-Mbomou: Launch of preventive vaccination against Ebola in Obo
March 19, 2026
(audio)
Following Bangui and several provinces, the city of Obo officially launched its preventive vaccination campaign against the Ebola virus on Tuesday, March 17. This operation primarily targets healthcare workers and members of the defense and security forces, considered the most exposed groups. By Aymard Gilles Quentin Mocki. We listen to him in remarks collected by Aymard Gilles Quentin Mocki.
The launch ceremony took place at the Obo District Hospital in the presence of local and health authorities. This initiative is part of a national strategy aimed at anticipating any epidemic risk by strengthening the immunity of frontline workers. The chief medical officer of the Haut-Mbomou health district, Dr. Armand Guezza, explained that the selection of beneficiaries reflects a need for strategic management of medical resources. Lacking sufficient stocks to cover the entire population, the government opted for targeted protection of professional categories considered at risk.
A strategic targeting of frontline actors
The program gives absolute priority to doctors, nurses, midwives, nursing assistants, community health workers, and laboratory personnel. Defense and security forces are also included as a secondary component. This rigorous selection process ensures the safety of those in direct contact with potential suspected cases, thus guaranteeing the continuity of health and security services in the event of an alert.
Four days of health mobilization
The campaign, scheduled to last four days, has already generated considerable enthusiasm, with many volunteers turning up as soon as it opened. To ensure the smooth running of the operation, two vaccination sites have been set up in the city: the Obo District Hospital and the AIM Medical Center. The strong involvement of administrative authorities and community health workers demonstrates the local commitment to strengthening health resilience in the face of cross-border infectious disease threats.
